Drugs Made In America Acquisition (DMAA) Accounts Payables (2024 - 2025)
Drugs Made In America Acquisition's (DMAA) quarterly Accounts Payables came in at $222184.0 in Q4 2025, up 187.51% YoY from $77280.0 in Q4 2024, and up 22118.4% on a QoQ basis from $1000.0 in Q2 2025.
Drugs Made In America Acquisition (DMAA) Accounts Payables (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAA) has 2 years of Accounts Payables data on file, last reported at $222184.0 in Q4 2025.
- Quarterly Accounts Payables rose 187.51% year-over-year to $222184.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $222184.0 (up 187.51% YoY) and the FY2025 annual result came in at $222184.0, up 187.51% from the prior year.
- Accounts Payables advanced to $222184.0 in Q4 2025, from $1000.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $222184.0 in Q4 2025 to a low of $1000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 58,428.00 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | - |
| 3 | Drugs Made In America Acquisition | 506.00 Mn | 506.00 Mn | - | 12,253.00 |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 25,000.00 |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | - |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 20,057.00 |
| 7 | Pioneer Acquisition I | 390.89 Mn | 653.32 Mn | - | - |
| 8 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 38,850.00 |
| 9 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | - |
| 10 | Drugs Made In America Acquisition | 215.62 Mn | 215.62 Mn | - | 254,412.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 222,184.00 |
| Jun 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 77,280.00 |